Biology Reference
In-Depth Information
27. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L et al (2009) A physical and
regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell
139(7):1255-1267
28. Stertz S, Shaw ML (2011) Uncovering the global host cell requirements for influenza virus
replication via RNAi screening. Microbes Infect 13(5):516-525
29. Sui B, Bamba D, Weng K, Ung H, Chang S, Van DJ et al (2009) The use of random homozy-
gous gene perturbation to identify novel host-oriented targets for influenza. Virology
387(2):473-481
30. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ et al (2008) Identification
of host proteins required for HIV infection through a functional genomic screen. Science
319(5865):921-926
31. König R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT et al (2008) Global analysis
of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135(1):49-60
32. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC et al (2008) Genome-scale RNAi
screen for host factors required for HIV replication. Cell Host Microbe 4(5):495-504
33. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S et al (2005) The
PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids
Res 33(Database issue):D284-D288
34. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, de Bono B et al (2009) Reactome
knowledgebase of human biological pathways and processes. Nucleic Acids Res 37(Database
issue):D619-D622
35. de Fougerolles AR (2008) Delivery vehicles for small interfering RNA in vivo. Hum Gene
Ther 19(2):125-132
36. Jackson AL, Linsley PS (2004) Noise amidst the silence: off-target effects of siRNAs? Trends
Genet 20(11):521-524
37. Dorsett Y, Tuschl T (2004) siRNAs: applications in functional genomics and potential as thera-
peutics. Nat Rev Drug Discov 3(4):318-329
38. Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J et al (2006) Position-specific
chemical modification of siRNAs reduces “off-target” transcript silencing. RNA
12(7):1197-1205
39. Ge Q, Filip L, Bai A, Nguyen T, Eisen HN, Chen J (2004) Inhibition of influenza virus produc-
tion in virus-infected mice by RNA interference. Proc Natl Acad Sci USA
101(23):8676-8681
40. Tompkins SM, Lo CY, Tumpey TM, Epstein SL (2004) Protection against lethal influenza
virus challenge by RNA interference in vivo. Proc Natl Acad Sci USA 101(23):8682-8686
41. Robbins M, Judge A, Ambegia E, Choi C, Yaworski E, Palmer L et al (2008) Misinterpreting
the therapeutic effects of small interfering RNA caused by immune stimulation. Hum Gene
Ther 19(10):991-999
42. Behlke MA (2006) Progress towards in vivo use of siRNAs. Mol Ther 13(4):644-670
43. Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein-protein interactions: pro-
gressing towards the dream. Nat Rev Drug Discov 3(4):301-317
44. Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A et al (2008) Maraviroc
for previously treated patients with R5 HIV-1 infection. N Engl J Med 359(14):1429-1441
45. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R et al (1996) Homozygous defect
in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1
infection. Cell 86(3):367-377
Search WWH ::
Custom Search